International Journal of Molecular Zoology 2024, Vol.14, No.1, 9-17 http://animalscipublisher.com/index.php/ijmz 17 Doudna J.A., 2020, The promise and challenge of therapeutic genome editing, Nature, 578(7794): 229-236. https://doi.org/10.1038/s41586-020-1978-5 PMid:32051598 PMCid:PMC8992613 Gurumurthy C.B., and Lloyd K.C.K., 2019, Generating mouse models for biomedical research: technological advances, Disease models & mechanisms, 12(1): dmm029462. https://doi.org/10.1242/dmm.029462 PMid:30626588 PMCid:PMC6361157 Khan S.H., 2019, Genome-editing technologies: concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application, Molecular Therapy-Nucleic Acids, 16: 326-334. https://doi.org/10.1016/j.omtn.2019.02.027 PMid:30965277 PMCid:PMC6454098 Liu K.L., Xu W.J., Hu P., and Pei Y., 2023, Research progress on genetic model of mouse with glaucoma, International Eye Science, 23(6): 933-937. Liu Y.R., Lian K.X., and Gu X.L., 2022, Research progress in mouse models of inflammatory diseases, Chinese Journal of Comparative Medicine, 32(12): 120-126. https://doi.org/10.1016/j.cclet.2021.04.023 Ma X.C., and Liu H.L., 2022, Application of CRISPR/Cas9 gene editing technology in the construction of animal models of ophthalmic diseases, Chinese Journal Of Experimental Ophthalmology, 40(10): 972-975. https://doi.org/10.57237/j.life.2022.01.002 Van Haasteren J., Li J., Scheideler O.J., Murthy N., and Schaffer D.V., 2020, The delivery challenge: fulfilling the promise of therapeutic genome editing, Nature biotechnology, 38(7): 845-855. https://doi.org/10.1038/s41587-020-0565-5 PMid:32601435 Yu H., Porciatti V., Lewin A., Hauswirth W., and Guy J., 2018, Longterm reversal of severe visual loss by mitochondrial gene transfer in a mouse model of Leber hereditary optic neuropathy, Sci. Rep., 8(1): 5587. https://doi.org/10.1038/s41598-018-23836-y PMid:29615737 PMCid:PMC5882860
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==